These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31730666)

  • 1. Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial.
    Anstey Watkins J; Ross JDC; Thandi S; Brittain C; Kai J; Griffiths F
    PLoS One; 2019; 14(11):e0224964. PubMed ID: 31730666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis.
    Armstrong-Buisseret L; Brittain C; David M; Dean G; Griffiths F; Hepburn T; Jackson L; Kai J; Montgomery A; Roberts T; Thandi S; Ross JDC
    Trials; 2019 Nov; 20(1):648. PubMed ID: 31775859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT.
    Armstrong-Buisseret L; Brittain C; Kai J; David M; Anstey Watkins J; Ozolins M; Jackson L; Abdali Z; Hepburn T; Griffiths F; Montgomery A; Daniels J; Manley A; Dean G; Ross JD
    Health Technol Assess; 2022 Jan; 26(2):1-170. PubMed ID: 35057905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence.
    Vodstrcil LA; Plummer EL; Doyle M; Fairley CK; McGuiness C; Bateson D; Hocking JS; Law MG; Petoumenos K; Donovan B; Chow EPF; Bradshaw CS;
    BMC Infect Dis; 2020 Nov; 20(1):834. PubMed ID: 33176727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial.
    Ross JDC; Brittain C; Anstey Watkins J; Kai J; David M; Ozolins M; Jackson L; Abdali Z; Hepburn TM; Griffiths F; Montgomery A; Daniels J; Manley A; Dean G; Armstrong-Buisseret LK
    BMC Womens Health; 2023 May; 23(1):241. PubMed ID: 37161454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a lactic acid plus lactoserum intimate liquid soap for external hygiene in the prevention of bacterial vaginosis recurrence after metronidazole oral treatment.
    Bahamondes MV; Portugal PM; Brolazo EM; Simões JA; Bahamondes L
    Rev Assoc Med Bras (1992); 2011; 57(4):415-20. PubMed ID: 21876923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis.
    Decena DC; Co JT; Manalastas RM; Palaypayon EP; Padolina CS; Sison JM; Dancel LA; Lelis MA
    J Obstet Gynaecol Res; 2006 Apr; 32(2):243-51. PubMed ID: 16594932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
    BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study.
    Plummer EL; Vodstrcil LA; Danielewski JA; Murray GL; Fairley CK; Garland SM; Hocking JS; Tabrizi SN; Bradshaw CS
    PLoS One; 2018; 13(1):e0190199. PubMed ID: 29293559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of bacterial vaginosis with high dosage metronidazole and lactic acid].
    Andreeva P; Slavchev B; Kovachev S; Nacheva A; Vacheva R
    Akush Ginekol (Sofiia); 2002; 41(5):36-9. PubMed ID: 12440337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.
    Plummer EL; Vodstrcil LA; Doyle M; Danielewski JA; Murray GL; Fehler G; Fairley CK; Bulach DM; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
    mBio; 2021 Oct; 12(5):e0232321. PubMed ID: 34663095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.
    Simoes JA; Bahamondes LG; Camargo RP; Alves VM; Zaneveld LJ; Waller DP; Schwartz J; Callahan MM; Mauck CK
    Br J Clin Pharmacol; 2006 Feb; 61(2):211-7. PubMed ID: 16433875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
    Plummer EL; Bradshaw CS; Doyle M; Fairley CK; Murray GL; Bateson D; Masson L; Slifirski J; Tachedjian G; Vodstrcil LA
    PLoS One; 2021; 16(2):e0246953. PubMed ID: 33571286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
    Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
    PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Dequalinium Chloride vs Metronidazole for the Treatment of Bacterial Vaginosis: A Randomized Clinical Trial.
    Raba G; Durkech A; Malík T; Bassfeld D; Grob P; Hurtado-Chong A;
    JAMA Netw Open; 2024 May; 7(5):e248661. PubMed ID: 38696172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria.
    Mitchell CM; Hitti JE; Agnew KJ; Fredricks DN
    BMC Infect Dis; 2009 Jun; 9():89. PubMed ID: 19515236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DEVA trial: protocol for a randomised controlled trial of dequalinium chloride versus usual care antibiotics for the treatment of bacterial vaginosis.
    Haydock R; Hepburn T; Ross J; Daniels J; Brittain C; Jackson L; Ozolins M; Wilson J
    Trials; 2022 Dec; 23(1):1040. PubMed ID: 36544202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and Treatment of Recurrent Bacterial Vaginosis.
    Faught BM; Reyes S
    J Womens Health (Larchmt); 2019 Sep; 28(9):1218-1226. PubMed ID: 31403349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.